Market Overview:
The global self testing diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of lifestyle diseases, rising demand for home-based tests, and technological advancements in self-testing diagnostics instruments and consumables. Based on type, the global self testing diagnostics market is segmented into instruments, consumables, and others. The instruments segment is further sub-segmented into point-of-care (POC) devices and laboratory analyzers. The consumables segment includes test strips, lancets/needles, collection cups/devices, control solutions/reagents etc., while others include software & services and data management systems. Based on application, the global self testing diagnostics market is divided into hospitals & clinics and others (including research laboratories & homes).
Product Definition:
Self Testing Diagnostics is the process of verifying the proper operation of a system or component by simulating failure conditions and observing the results. The importance of Self Testing Diagnostics is that it allows you to verify the proper operation of a system or component before putting it into use, which can help prevent failures and downtime.
Instruments:
Instruments, also known as diagnostic devices or lab equipment are used for testing and monitoring purposes. They comprise of various components such as sensors, microprocessors, computer software and/or electronic circuits that help in collecting information regarding the targeted phenomenon. The most commonly used instruments in medical diagnostics include Clinical Laboratory Improvement Amendments (CLIA) compliant clinical laboratory instruments & kits along with other non-CLIA compliant clinical laboratory instruments & kits. CLIA is a U.
Consumables:
Consumables are the instruments or devices that are used by healthcare professionals to diagnose a disease condition. It can be any tool, device or kit that is used in the diagnosis of any medical condition. Consumables also include reagents and kits which can be used for testing purposes by lay people as well as healthcare professionals.
The global self-testing diagnostics market is driven by factors such as increasing demand for home care services, rising geriatric population base.
Application Insights:
The global self testing diagnostics market by application is categorized into hospitals, clinics, and others. The hospitals segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as presence of a large number of patients with chronic diseases requiring regular checkups and/or follow-ups for early detection and management of disease conditions. Furthermore, an increase in the prevalence rate for various chronic diseases such as cancer across the globe has also driven demand for SSTD over the past few years.
The clinics segment is expected to witness lucrative growth over the forecast period owing to increasing awareness about preventive healthcare among consumers coupled with rising spending on healthcare services by private organizations, governments, and businesses globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for technologically advanced products, and increasing healthcare expenditure in this region. Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing awareness about self testing diagnostics among end-users. Moreover, an increase in government initiatives aimed at reducing disease burden is also anticipated to drive regional market growth during the forecast period. For instance, ‘Hospital Diagnostic Services Program (HDSP)’ by Ministry of Health & Family Welfare, Government of India was launched with an aim to reduce hospital stays through early diagnosis which ultimately leads towards cost reduction for patients as well as hospitals.
Growth Factors:
- Increasing incidence of lifestyle diseases: The global prevalence of lifestyle diseases such as diabetes, heart disease, and cancer is increasing at an alarming rate. This is primarily due to changing lifestyles and dietary habits. There is a growing need for early diagnosis and treatment of these diseases, which has led to the growth of the self-testing diagnostics market.
- Rising demand for home-based tests: Home-based tests are becoming increasingly popular due to their convenience and affordability. They allow patients to test themselves for various conditions without having to go through the hassle of visiting a doctor or a clinic. This has helped fuel the growth of the self-testing diagnostics market in recent years.
- Advances in technology: Technological advances have led to the development of novel self-testing diagnostic devices that are easier and faster to use than traditional methods. These devices are also more accurate and provide results within minutes instead of hours or days like earlier methods did .This has helped boost demand for self-testing diagnostics products worldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Self Testing Diagnostics Market Research Report
By Type
Instruments, Consumables, Others
By Application
Hospitals, Clinics, Others
By Companies
Bionime, Roche, Quidel, True Diagnostics, BD, Abbott, Agilent Technologies, Bayer, Trinity Biotech, Arkray, Bionime
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Self Testing Diagnostics Market Report Segments:
The global Self Testing Diagnostics market is segmented on the basis of:
Types
Instruments, Consumables, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bionime
- Roche
- Quidel
- True Diagnostics
- BD
- Abbott
- Agilent Technologies
- Bayer
- Trinity Biotech
- Arkray
- Bionime
Highlights of The Self Testing Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Consumables
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Self Testing Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Self-testing diagnostics is a term used to describe the process of conducting self-diagnostic tests on equipment or systems in order to identify and correct any problems.
Some of the key players operating in the self testing diagnostics market are Bionime, Roche, Quidel, True Diagnostics, BD, Abbott, Agilent Technologies, Bayer, Trinity Biotech, Arkray, Bionime.
The self testing diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Self Testing Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Self Testing Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Self Testing Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Self Testing Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Self Testing Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Self Testing Diagnostics Market Size and Y-o-Y Growth
4.5.2 Self Testing Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Self Testing Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Self Testing Diagnostics Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Self Testing Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Self Testing Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Self Testing Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Self Testing Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Self Testing Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Self Testing Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Self Testing Diagnostics Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Consumables
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Self Testing Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Self Testing Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Self Testing Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Self Testing Diagnostics Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Consumables
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Self Testing Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Self Testing Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Self Testing Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Self Testing Diagnostics Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Consumables
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Self Testing Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Self Testing Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Self Testing Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Self Testing Diagnostics Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Consumables
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Self Testing Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Self Testing Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Self Testing Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Self Testing Diagnostics Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Consumables
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Self Testing Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Self Testing Diagnostics Market: Competitive Dashboard
14.2 Global Self Testing Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bionime
14.3.2 Roche
14.3.3 Quidel
14.3.4 True Diagnostics
14.3.5 BD
14.3.6 Abbott
14.3.7 Agilent Technologies
14.3.8 Bayer
14.3.9 Trinity Biotech
14.3.10 Arkray
14.3.11 Bionime
